Sage Journals: Discover world-class research

Abstract

Background: Glutamine (GLN) has been shown to improve outcome after experimental and clinical models of critical illness. Enhanced expression of heat shock protein (HSP) has been hypothesized to be responsible for this protection. The heat shock response has been shown to inhibit inducible nitric oxide synthase (iNOS) gene expression and nitric oxide (NO) production. This study tested the hypothesis that GLN-mediated activation of the HSP pathway is responsible for improved survival and attenuation of iNOS expression after an inflammatory cytokine–induced injury. Methods: Heat shock factor-1 (HSF-1) wild-type and knockout mouse embryonic fibroblasts (HSF-1+/+ and HSF-1–/–) were used in all experiments. Cells were treated with 0 mmol/L or 8 mmol/L GLN and cytomix (tumor necrosis factor-α, lipopolysaccharide, and interferon-γ) in a concurrent treatment model once they had reached confluence. Cell viability was assayed with MTS/PMS mixture. Apoptosis and necrosis were assayed via immunohistochemistry. iNOS and HSP-70 expression were detected via Western blotting. NO production was measured using the Griess reagent. Results: GLN treatment significantly attenuated inflammatory cytokine–induced cell death and apoptosis in HSF-1+/+ cells vs 0 mmol/L GLN treatment; however, GLN′s cellular protection was lost in HSF-1–/– cells. GLN supplementation attenuated cytomix-induced iNOS expression and NO production only in HSF-1+/+ cells. Further, GLN induced HSP-70 expression only in HSF-1+/+ cells. Conclusions: This is the first demonstration that GLN-mediated cellular protection after inflammatory cytokine injury is due to HSF-1 expression and cellular capacity to activate an HSP response.

Inflammatory injury contributes to morbidity and mortality in critical illness. Glutamine can improve outcome after critical illness without clear mechanism. We found glutamine attenuates cellular injury and inducible nitric oxide synthase expression after inflammatory cytokine induced-injury. This is the first demonstration that glutamine’s protection against injury is dependent on the presence of heat shock factor-1, the transcription factor responsible for heat shock protein expression.

Get full access to this article

View all access options for this article.

References

Increase in national hospital discharge survey rates for septicemia: United States, 1979–1987. MMWR Morb Mortal Wkly Rep. 1990;39:31– 34.

Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303– 1310.

Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS): a prospective study. JAMA. 1995 ;273:117– 123.

Wheeler AP, Bernard GR. Treating patients with severe sepsis.N Engl J Med. 1999;340:207– 214.

Murphy SL. Deaths: final data for 1998. Natl Vital Stat Rep. 2000;48:1– 105.

Giusti-Paiva A, De Castro M, Antunes-Rodrigues J, Carnio EC. Inducible nitric oxide synthase pathway in the central nervous system and vasopressin release during experimental septic shock. Crit Care Med. 2002;30:1306– 1310.

Hierholzer C, Harbrecht B, Menezes JM, et al. Essential role of induced nitric oxide in the initiation of the inflammatory response after hemorrhagic shock. J Exp Med. 1998 ;187:917– 928.

Wong HR, Carcillo JA, Burckart G, Shah N, Janosky JE. Increased serum nitrite and nitrate concentrations in children with the sepsis syndrome.Crit Care Med. 1995;23:835– 842.

Szabo C, Billiar TR. Novel roles of nitric oxide in hemorrhagic shock. Shock. 1999;12:1– 9.

10.

Vo PA, Lad B, Tomlinson JA, Francis S, Ahluwalia A. Autoregulatory role of endothelium-derived nitric oxide (NO) on lipopolysaccharide-induced vascular inducible NO synthase expression and function. J Biol Chem. 2005;280:7236– 7243.

11.

Chabrier PE, Demerle-Pallardy C, Auguet M. Nitric oxide synthases: targets for therapeutic strategies in neurological diseases. Cell Mol Life Sci. 1999;55:1029– 1035.

12.

Flaring UB, Rooyackers OE, Wernerman J, Hammarqvist F. Glutamine attenuates post-traumatic glutathione depletion in human muscle. Clin Sci (Lond). 2003;104:275– 282.

13.

Wischmeyer PE. Can glutamine turn off the motor that drives systemic inflammation? Crit Care Med. 2005 ;33:1175– 1178.

14.

Lacey JM, Wilmore DW. Is glutamine a conditionally essential amino acid? Nutr Rev. 1990;48:297– 309.

15.

Novak F, Heyland DK, Avenell A, Drover JW, Su X. Glutamine supplementation in serious illness: a systematic review of the evidence.Crit Care Med. 2002;30:2022– 2029.

16.

Chow A, Zhang R. Glutamine reduces heat shock-induced cell death in rat intestinal epithelial cells. J Nutr. 1998 ;128:1296– 1301.

17.

Singleton KD, Serkova N, Banerjee A, Meng X, Gamboni-Robertson F, Wischmeyer PE. Glutamine attenuates endotoxin-induced lung metabolic dysfunction: potential role of enhanced heat shock protein 70.Nutrition. 2005;21:214– 223.

18.

Singleton KD, Serkova N, Beckey VE, Wischmeyer PE. Glutamine attenuates lung injury and improves survival after sepsis: role of enhanced heat shock protein expression. Crit Care Med. 2005 ;33:1206– 1213.

19.

Wischmeyer PE, Jayakar D, Williams U, Singleton KD, Serkova N. Single dose of glutamine preserves myocardial tissue metabolism, glutathione content, and enhances myocardial function following ischemia-reperfusion injury. JPEN J Parenter Enteral Nutr. 2003 ;27:396– 403.

20.

Wischmeyer PE, Kahana M, Wolfson R, Ren H, Musch MM, Chang EB. Glutamine reduces cytokine release, organ damage, and mortality in a rat model of endotoxemia. Shock. 2001 ;16:398– 402.

21.

Wischmeyer PE, Kahana M, Wolfson R, Ren H, Musch MM, Chang EB. Glutamine induces heat shock protein and protects against endotoxin shock in the rat. J Appl Physiol. 2001 ;90:2403– 2410.

22.

Wischmeyer PE, Musch MW, Madonna MB, Thisted R, Chang EB. Glutamine protects intestinal epithelial cells: role of inducible HSP70. Am J Physiol. 1997;272(4 pt 1): G879–G884.

23.

Uehara K, Takahashi T, Fujii H, et al. The lower intestinal tract-specific induction of heme oxygenase-1 by glutamine protects against endotoxemic intestinal injury. Crit Care Med. 2005 ;33:381– 390.

24.

Feinstein DL, Galea E, Aquino DA, Li GC, Xu H, Reis DJ. Heat shock protein 70 suppresses astroglial-inducible nitric-oxide synthase expression by decreasing NFkappaB activation. J Biol Chem. 1996 ;271:17724– 17732.

25.

Hauser GJ, Dayao EK, Wasserloos K, Pitt BR, Wong HR. HSP induction inhibits iNOS mRNA expression and attenuates hypotension in endotoxin-challenged rats. Am J Physiol. 1996 ;271(6 pt 2):H2529– H2535.

26.

Wong HR, Ryan M, Wispe JR. The heat shock response inhibits inducible nitric oxide synthase gene expression by blocking I kappa-B degradation and NF-kappa B nuclear translocation. Biochem Biophys Res Commun. 1997;231:257– 263.

27.

Kiang JG, Bowman PD, Wu BW, et al. Geldanamycin treatment inhibits hemorrhage-induced increases in KLF-6 and iNOS expression in unresuscitated mouse organs: role of inducible HSP70. J Appl Physiol. 2004 ;97:564– 569.

28.

Pittet JF, Lu LN, Geiser T, Lee H, Matthay MA, Welch WJ. Stress preconditioning attenuates oxidative injury to the alveolar epithelium of the lung following haemorrhage in rats. J Physiol. 2002 ;538(pt 2):583– 597.

29.

Malhotra V, Eaves-Pyles T, Odoms K, Quaid G, Shanley TP, Wong HR. Heat shock inhibits activation of NF-kappaB in the absence of heat shock factor-1. Biochem Biophys Res Commun. 2002 ;291:453– 457.

30.

Malhotra V, Kooy NW, Denenberg AG, Dunsmore KE, Wong HR. Ablation of the heat shock factor-1 increases susceptibility to hyperoxia-mediated cellular injury. Exp Lung Res. 2002 ;28:609– 622.

31.

Wu F, Wilson JX, Tyml K. Ascorbate inhibits iNOS expression and preserves vasoconstrictor responsiveness in skeletal muscle of septic mice.Am J Physiol Regul Integr Comp Physiol. 2003 ;285:R50– R56.

32.

Wischmeyer PE, Vanden Hoek TL, Li C, et al. Glutamine preserves cardiomyocyte viability and enhances recovery of contractile function after ischemia-reperfusion injury. JPEN J Parenter Enteral Nutr. 2003 ;27:116– 122.

33.

Ziegler TR, Ogden LG, Singleton KD, et al. Parenteral glutamine increases serum heat shock protein 70 in critically ill patients.Intensive Care Med. 2005 ;31:1079– 1086.

34.

Xiao X, Zuo X, Davis AA, et al. HSF1 is required for extra-embryonic development, postnatal growth and protection during inflammatory responses in mice. EMBO J. 1999 ;18:5943– 5952.

35.

Christians ES, Yan LJ, Benjamin IJ. Heat shock factor 1 and heat shock proteins: critical partners in protection against acute cell injury.Crit Care Med. 2002 ;30(1 suppl):S43– S50.

36.

Lopez A, Lorente JA, Steingrub J, et al. Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock.Crit Care Med. 2004;32:21– 30.

37.

Dinkova-Kostova AT, Liby KT, Stephenson KK, et al. Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress. Proc Natl Acad Sci U S A. 2005;102:4584– 4589.

38.

Hanson JL, Anest V, Reuther-Madrid J, Baldwin AS. Oncoprotein suppression of tumor necrosis factor-induced NF kappa B activation is independent of Raf-controlled pathways. J Biol Chem. 2003 ;278:34910– 34917.

39.

Dijkmans R, Van Damme J, Cornette F, Heremans H, Billiau A. Bacterial lipopolysaccharide potentiates gamma interferon-induced cytotoxicity for normal mouse and rat fibroblasts. Infect Immun. 1990 ;58:32– 36.

40.

Ngai KC, Yeung CY. Additive effect of tumor necrosis factor-alpha and endotoxin on bilirubin cytotoxicity. Pediatr Res. 1999 ;45(4 pt 1):526– 530.

41.

Weiss YG, Bouwman A, Gehan B, Schears G, Raj N, Deutschman CS. Cecal ligation and double puncture impairs heat shock protein 70 (HSP-70) expression in the lungs of rats. Shock. 2000 ;13:19– 23.

42.

Weiss YG, Maloyan A, Tazelaar J, Raj N, Deutschman CS. Adenoviral transfer of HSP-70 into pulmonary epithelium ameliorates experimental acute respiratory distress syndrome. J Clin Invest. 2002 ;110:801– 806.

43.

Kiang JG. Inducible heat shock protein 70 kD and inducible nitric oxide synthase in hemorrhage/resuscitation-induced injury. Cell Res. 2004;14:450– 459.

Glutamine Attenuation of Cell Death and Inducible Nitric Oxide Synthase Expression Following Inflammatory Cytokine-Induced Injury Is Dependent on Heat Shock Factor-1 Expression

Abstract

Get full access to this article

References